Neurostimulation Market Growth, Size, Share, Trends, and Forecast 2032

Neurostimulation Market

Neurostimulation Market Analysis By Therapies (Spinal Cord, Sacral Nerve, Transcranial Magnetic, TENS, Deep Brain, and Vagus Nerve & Gastric), Application (Epilepsy, Urinary & Fecal Incontinence, Dystonia, Parkinson’s Disease, Pain Management, Essential Tremor, Depression, Gastroparesis, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032-

Category: Medical Device Report Format : PDF Pages: 201 Report Code: ZMR-804 Published Date: Jul-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 6.64 Billion USD 19.11 Billion 12.58% 2023

Neurostimulation Market

Request Free Sample

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Neurostimulation Market, 2016 – 2026 (USD Billion)
    • 3.2.Global Neurostimulation Market: Snapshot
  • Chapter 4.Neurostimulation Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Neurostimulation
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technology Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Neurostimulation Market Attractiveness, By Therapies
    • 5.2.Global Neurostimulation Market Attractiveness, By Application
    • 5.3.Global Neurostimulation Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Neurostimulation Market: Company Market Share, 2019
    • 6.2.Strategic Developments
    • 7.1.Global Neurostimulation Market Overview: by Therapies
      • 7.1.1.Global Neurostimulation Market Revenue Share, by Therapies, 2019 & 2026
    • 7.2.Global Neurostimulation Market Analysis/Overview – By Therapies
      • 7.2.1.Spinal Cord – Overview/Analysis
      • 7.2.2.Sacral Nerve – Overview/Analysis
      • 7.2.3.Transcranial Magnetic – Overview/Analysis
      • 7.2.4.TENS – Overview/Analysis
      • 7.2.5.Deep Brain – Overview/Analysis
      • 7.2.6.Vagus Nerve & Gastric – Overview/Analysis
    • 7.3.Spinal Cord
      • 7.3.1.Global Neurostimulation Market for Spinal Cord, Revenue (USD Billion) 2016 - 2026
    • 7.4.Sacral Nerve
      • 7.4.1.Global Neurostimulation Market for Sacral Nerve, Revenue (USD Billion) 2016 - 2026
    • 7.5.Transcranial Magnetic
      • 7.5.1.Global Neurostimulation Market for Transcranial Magnetic, Revenue (USD Billion) 2016 - 2026
    • 7.6.TENS
      • 7.6.1.Global Neurostimulation Market for TENS, Revenue (USD Billion) 2016 - 2026
    • 7.7.Deep Brain
      • 7.7.1.Global Neurostimulation Market for Deep Brain, Revenue (USD Billion) 2016 - 2026
    • 7.8.Vagus Nerve & Gastric
      • 7.8.1.Global Neurostimulation Market for Vagus Nerve & Gastric, Revenue (USD Billion) 2016 - 2026
    • 8.1.Global Neurostimulation Market Overview: by Application
      • 8.1.1.Global Neurostimulation Market Revenue Share, by Application, 2019 & 2026
    • 8.2.Global Neurostimulation Market Analysis/Overview – By Application
      • 8.2.1.Epilepsy – Overview/Analysis
      • 8.2.2.Urinary & Fecal Incontinence – Overview/Analysis
      • 8.2.3.Dystonia – Overview/Analysis
      • 8.2.4.Parkinson’s Disease – Overview/Analysis
      • 8.2.5.Pain Management – Overview/Analysis
      • 8.2.6.Essential Tremor – Overview/Analysis
      • 8.2.7.Depression – Overview/Analysis
      • 8.2.8.Gastroparesis – Overview/Analysis
      • 8.2.9.Others – Overview/Analysis
    • 8.3.Epilepsy
      • 8.3.1.Global Neurostimulation Market for Epilepsy, Revenue (USD Billion) 2016 - 2026
    • 8.4.Urinary & Fecal Incontinence
      • 8.4.1.Global Neurostimulation Market for Urinary & Fecal Incontinence, Revenue (USD Billion) 2016 - 2026
    • 8.5.Dystonia
      • 8.5.1.Global Neurostimulation Market for Dystonia, Revenue (USD Billion) 2016 - 2026
    • 8.6.Parkinson’s Disease
      • 8.6.1.Global Neurostimulation Market for Parkinson’s Disease, Revenue (USD Billion) 2016 - 2026
    • 8.7.Pain Management
      • 8.7.1.Global Neurostimulation Market for Pain Management, Revenue (USD Billion) 2016 - 2026
    • 8.8.Essential Tremor
      • 8.8.1.Global Neurostimulation Market for Essential Tremor, Revenue (USD Billion) 2016 - 2026
    • 8.9.Depression
      • 8.9.1.Global Neurostimulation Market for Depression, Revenue (USD Billion) 2016 - 2026
    • 8.1.Gastroparesis
      • 8.10.1.Global Neurostimulation Market for Gastroparesis, Revenue (USD Billion) 2016 - 2026
    • 8.11.Others
      • 8.11.1.Global Neurostimulation Market for Others, Revenue (USD Billion) 2016 - 2026
  • Chapter 9.Neurostimulation Market – Regional Analysis
    • 9.1.Global Neurostimulation Market: Regional Overview
      • 9.1.1.Global Neurostimulation Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2.Global Neurostimulation Market Revenue, by Region, 2016 – 2026 (USD Billion)
    • 9.2.North America
      • 9.2.1.North America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.2.2.North America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.2.3.North America Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.2.4.North America Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.2.5. U.S.
      • 9.2.6.Canada
    • 9.3.Europe
      • 9.3.1.Europe Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.3.2.Europe Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.3.3.Europe Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.3.4.Europe Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.3.5.Germany
      • 9.3.6.France
      • 9.3.7. U.K.
      • 9.3.8.Italy
      • 9.3.9.Spain
      • 9.3.10.Rest of Europe
    • 9.4.Asia Pacific
      • 9.4.1.Asia Pacific Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.4.2.Asia Pacific Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.4.3.Asia Pacific Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.4.4.Asia Pacific Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.4.5.China
      • 9.4.6.Japan
      • 9.4.7.India
      • 9.4.8.South Korea
      • 9.4.9.South-East Asia
      • 9.4.10.Rest of Asia Pacific
    • 9.5.Latin America
      • 9.5.1.Latin America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.5.2.Latin America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.5.3.Latin America Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.5.4.Latin America Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.5.5.Brazil
      • 9.5.6.Mexico
      • 9.5.7.Rest of Latin America
    • 9.6.The Middle-East and Africa
      • 9.6.1.The Middle-East and Africa Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.6.2.The Middle-East and Africa Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.6.3.The Middle-East and Africa Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.6.4.The Middle-East and Africa Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.6.5.GCC Countries
      • 9.6.6.South Africa
      • 9.6.7.Rest of Middle-East Africa
  • Chapter 10.Company Profiles
    • 10.1.Cyberonics Inc.
      • 10.1.1.Company Overview
      • 10.1.2.Financial Overview
      • 10.1.3.Product Portfolio
      • 10.1.4.Business Strategy
      • 10.1.5.Recent Developments
    • 10.2.Medtronic Inc.
    • 10.3.CVRx Inc.
    • 10.4.Boston Scientific Corp.
    • 10.5.St. Jude Medical Inc.
    • 10.6.Neuropace Inc.
    • 10.7.Aleva Neurotherapeutics SA
    • 10.8.Bioness Inc.
    • 10.9.EnteroMedics Inc.
    • 10.1.NeuroSigma Inc.
    • 10.11.BioContrul Medical
    • 10.12.LivaNova PLC
    • 10.13.Synapse Biomedical Inc
    • 10.14.Others

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 5 Porter’s Five Forces Analysis for Global Neurostimulation Market
FIG. 6 Global Neurostimulation Market Attractiveness, By Therapies
FIG. 7 Global Neurostimulation Market Attractiveness, By Application
FIG. 8 Global Neurostimulation Market Attractiveness, By End-User
FIG. 9 Company Share Analysis, 2019
FIG. 10 Global Neurostimulation Market Revenue Share, by Therapies, 2019 & 2026
FIG. 11 Global Neurostimulation Market for Spinal Cord, Revenue (USD Billion) 2016 - 2026
FIG. 12 Global Neurostimulation Market for Sacral Nerve, Revenue (USD Billion) 2016 - 2026
FIG. 13 Global Neurostimulation Market for Transcranial Magnetic, Revenue (USD Billion) 2016 - 2026
FIG. 14 Global Neurostimulation Market for TENS, Revenue (USD Billion) 2016 - 2026
FIG. 15 Global Neurostimulation Market for Deep Brain, Revenue (USD Billion) 2016 - 2026
FIG. 16 Global Neurostimulation Market for Vagus Nerve & Gastric, Revenue (USD Billion) 2016 - 2026
FIG. 17 Global Neurostimulation Market Revenue Share, by Application, 2019 & 2026
FIG. 18 Global Neurostimulation Market for Epilepsy, Revenue (USD Billion) 2016 - 2026
FIG. 19 Global Neurostimulation Market for Urinary & Fecal Incontinence, Revenue (USD Billion) 2016 - 2026
FIG. 20 Global Neurostimulation Market for Dystonia, Revenue (USD Billion) 2016 - 2026
FIG. 21 Global Neurostimulation Market for Parkinson’s Disease, Revenue (USD Billion) 2016 - 2026
FIG. 22 Global Neurostimulation Market for Pain Management, Revenue (USD Billion) 2016 - 2026
FIG. 23 Global Neurostimulation Market for Essential Tremor, Revenue (USD Billion) 2016 - 2026
FIG. 24 Global Neurostimulation Market for Depression, Revenue (USD Billion) 2016 - 2026
FIG. 25 Global Neurostimulation Market for Gastroparesis, Revenue (USD Billion) 2016 - 2026
FIG. 26 Global Neurostimulation Market for Others, Revenue (USD Billion) 2016 - 2026
FIG. 27 Global Neurostimulation Market Revenue Share, by Region, 2019 & 2026
FIG. 28 North America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 29 Europe Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 30 Asia Pacific Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 31 Latin America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 32 The Middle-East and Africa Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 33 Cyberonics Inc. Business Segment Revenue Share, 2018 (%)
FIG. 34 Cyberonics Inc. Geographical Segment Revenue Share, 2018 (%)
 


Table Of Tables

List of Tables

TABLE 1 Global Neurostimulation Market: Snapshot
TABLE 2 Drivers of the Neurostimulation Market: Impact Analysis
TABLE 3 Restraints for the Neurostimulation Market: Impact Analysis
TABLE 4 Global Neurostimulation Market Revenue, by Region, 2016 – 2026 (USD Billion)
TABLE 5 North America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 6 North America Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 7 North America Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 8 Europe Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 9 Europe Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 10 Europe Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 11 Asia Pacific Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 12 Asia Pacific Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 13 Asia Pacific Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 14 Latin America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 15 Latin America Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 16 Latin America Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 17 The Middle-East and Africa Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 18 The Middle-East and Africa Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 19 The Middle-East and Africa Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)

Methodology

FrequentlyAsked Questions

Neurostimulation uses electrical impulses to stimulate nerves. It is used to treat pain, neurological disorders, and movement issues.
The global Neurostimulation market is expected to be driven by the rising neurological disorders, demand for non-drug therapies, and technological advancements. Adoption in pain management and neurology supports expansion.
According to study, the global Neurostimulation market size was worth around USD 6.64 Billion in 2023 and is predicted to grow to around USD 19.11 Billion By 2032.
The global Neurostimulation market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 12.58% during the forecast period from 2024-2032.
The global Neurostimulation industry is projected to be challenged by Challenges include high device costs, invasive procedure risks, and strict regulatory approvals.
The Opportunities include rising neurological disorder prevalence, pain management demand, advances in minimally invasive devices, and expanding clinical adoption will offer significant growth opportunities in the Neurostimulation market.
Implantable and non-invasive stimulation devices; closed-loop systems with real-time feedback; expanding applications in chronic pain and neurology are the emerging trends and innovations impacting the Neurostimulation market.
The global Neurostimulation market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Neurostimulation market are; Cyberonics Inc., Medtronic Inc., CVRx Inc., Boston Scientific Corp., St. Jude Medical Inc., and Neuropace Inc, Aleva Neurotherapeutics SA, Bioness Inc., EnteroMedics Inc., NeuroSigma Inc., BioControl Medical, LivaNova PLC, and Synapse Biomedical Inc, among others and others.
The report explores crucial aspects of the Neurostimulation market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Industry Perspective:OverviewGrowth FactorsNeurosimulation Report ScopeSegmentationRegional AnalysisSegments Included in Report

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed